Medical Advocates for Social Justice
Kaletra Library Service   Conference Abstracts and Posters
Kaletra Library Service Conference Abstracts and Posters
	Index of  Abstracts and Posters from   40th Interscience Conference on Antimicrobial  Agents and Chemotherapy (ICAAC)  Toronto, Canada
	September 17 -  September 20, 2000

Last updated:  December 08, 2014  

Assessment of the Bioequivalence and Food Effects for Liquid and Soft Elastic Capsule Co-formulations of ABT-378/ritonavir (ABT-378/r) in Healthy Subjects  Gustavson L, Lam W, Bertz R, Hsu A, Rynkiewicz K, Qi J, Ghosh S, Facey I, Bernstein B, Sun E,  (40ICAAC)
Abstract

Concomitant Administration of ABT-378/ritonavir (ABT-378/r) Results in a Clinically Important Pharmacokinetic (PK) Interaction with Atorvastatin (ATO) but not Pravastatin (PRA) Carr R, Andre A, Bertz R, Lam W, Chang M, Chen P, Williams L, Bernstein B, Sun E (40ICAAC)
Abstract

        LPV/RTV/EFV     

Trough Concentration-EC50 Relationship as a Predictor of Viral Response for ABT-378/Ritonavir (ABT-378/r) in Treatment-Experienced Patients HSU A, Isaacson J, Kempf D, King M, Rode R, Lam W, Bruni S, Bernstein B, Sun E, Granneman G. (40ICAAC)  
Abstract

Analysis of Viral Isolates Following Viral Load Rebound on Therapy with ABT-378/ritonavir (ABT-378/r)  Brun S, Kempf D, Molla A, Mo H, Xu Y, Real K, Poddig J, Hertogs K, Larder B, Freimuth W, Japour A, Sun E.  (40ICAAC)  
Abstract

Definition of Genotypic Breakpoints for ABT-378/Ritonavir (ABT-378/r) for Use in the Interpretation of HIV Resistance Testing  Kempf D, Isaacson J, King M, Rode R, Brun S, Xu Y, Real K, Hsu A, Granneman G, Lie Y, Hellmann N, Bernstein B, Sun E. (40ICAAC) 
Abstract

Two Year Follow Up of ABT-378/ritonavir (ABT-378/r) in Antiretroviral Naïve HIV+ Patients Benson, C, Brun S, King M, Real K, Murphy R , Hicks C, Eron J, Thommes J, Gulick R, Glesby G, Thompson M, White C, Albrecht M, Kessler H, Poddig J, Sun E, Japour A. (40ICAAC) 
Abstract

Efficacy of ABT-378/r vs Nelfinavir (NFV) in Antiretroviral (ARV)-Naïve Subjects: Results of a Phase III Blinded Randomized Clinical Trial Walmsley S. Badley A, Beall G, Cameron W, Johnson D, Johnson M, Ruane P, Rubio R, Stryker R, King M, Cernohous P, Moseley J, Opferman M, Sattler M, Bernstein B, Sun S. (40ICAAC) 
Abstract

    LPV/RTV/EFV

Assessment of the Pharmacokinetic Interaction between ABT-378/ritonavir (ABT-378/r) and Efavirenz (EFV) in Healthy Volunteers and in HIV+ Subjects Bertz R, Lam W, Hsu A, Rynkiewicz K, Foit C, Bryan P, Synlte J, Brun S, Granneman G, Sun E. (40ICAAC)
Abstract

ABT-378/ritonavir (ABT-378/r) and Efavirenz: 24 week Safety/Efficacy Evaluation in Multiple PI Experienced Patients Brun S, Bertz R, Xu L, Clumeck N, Lazzarin A, Rockstroh J, Girard P, Telent A, Bergmann F, Danner S, Ho D, Tubiana R, Carosi G, Sylte J, Hsu A, Kempf D, Sun E,   (40ICAAC)
Abstract

---

Main New/Newsworthy

Kaletra Conference Data

Home

---

Index of Lopinavir/Ritonavir Data Presented at  40th Interscience Conference on Antimicrobial Agents and Chemotherapy    © 2000/2002 Medical Advocates for Social Justice